Tag: biotechnology
-
Genentech, Biotech Partner on Multiple Sclerosis
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech.
-
Trial Shows Immunotherapies Extend Life with Melanoma
First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers.
-
Crispr Enhanced for RNA Editing
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases.
-
Voice Indicators to Monitor Dementia Progression
A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia.
-
Immunotherapy Biotech Gains $325M in Venture Funds
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round.
-
Stem Cell Start-Up Raises $250M in Venture Funds
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing.
-
Trial Testing Paramedic-Delivered Stroke Drug
A clinical trial is getting underway testing a treatment for stroke delivered to patients by emergency medical technicians on the way to the hospital.
-
Artificial DNA Designed to Control Drug Delivery
Researchers in Germany are developing techniques with artificial DNA and hydrogel designed to control the sequence of drugs delivered into the body.
-
Two Biotechs Each Issue $300M+ IPOs
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions.
-
Company Launches Attacking Cancer Proteins, Lands $67M
A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies.